Maduck Sean sold $2.2M of CORT
Maduck Sean (See Remarks) sold 25,000 shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $88.35 ($87.33–$89.31, $2.21M total) across 3 trades on 2026-07-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A $2.21M open-market sale by an officer can create minor sentiment noise, but the presence of a pre-arranged 10b5-1 plan reduces interpretive weight.
Market read
Traders may note the insider sale for sentiment monitoring, but there is no new fundamental catalyst in the text.
What to watch
The article lacks context on total insider holdings history, other concurrent insider trades, and whether the sale was part of a broader scheduled program.
Background
The article is an SEC Form 4 insider transaction disclosure for Corcept Therapeutics, reported by officer Maduck Sean.
Ticker impact
Corcept Therapeutics Form 4 shows officer Maduck Sean sold 25,000 shares in open-market trades for about $2.21M under a 10b5-1 plan.
Likely limited near-term impact; any reaction is typically small and short-lived unless accompanied by other new company-specific news.
The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan; the article provides no new operational, financial, or regulatory developments.
Market effects
No direct sector read-through; this is company-specific insider liquidity activity.
None indicated.
None indicated.
Counterpoint
Insider sales under a 10b5-1 plan can be purely mechanical (tax/liquidity) and may not signal reduced confidence.
Key entities
- issuerCorcept Therapeutics Inc
Subject of the Form 4 insider transaction; officer Maduck Sean sold shares under a 10b5-1 plan.
- insiderMaduck Sean
Officer who executed the open-market sale of 25,000 shares on 2026-07-01.
